Below is the published article detailing the results of the three-arm phase II study
of everolimus and estrogen deprivation therapy (EDT) in advanced FLC. These results were published in May 2020.
Our new AI assistant can help patients, caregivers, and researchers find important information faster. Click the logo in the lower right corner to try it.